Pathway analysis of genome-wide association studies for Parkinson's disease

被引:17
|
作者
Song, Gwan Gyu [1 ]
Lee, Young Ho [1 ]
机构
[1] Korea Univ, Coll Med, Anam Hosp, Div Rheumatol,Dept Internal Med, Seoul 136705, South Korea
关键词
Parkinson's disease; Genome-wide association study; Pathway-based analysis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUSCEPTIBILITY GENES; MOLECULAR NETWORKS; SNPS; IDENTIFICATION; REGION; ITGAM; RISK; MAPT; TOOL;
D O I
10.1007/s11033-012-2346-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The study was done to identify the candidate causal single nucleotide polymorphisms (SNPs) and candidate causal mechanisms that contribute to Parkinson's disease (PD) susceptibility and to generate a SNP to ene to pathway hypothesis using an analytical pathway-based approach. We used a PD genome-wide association study (GWAS) meta-analysis data of the genotypes of 2,525,705 SNPs in 4,238 PD cases and 4,239 controls. Identify candidate Causal SNPs and Pathways (ICSNPathway) analysis was applied to the PD GWAS dataset. The first stage involved the pre-selection of candidate causal SNPs by linkage disequilibrium analysis and the functional SNP annotation of the most significant SNPs found. The second stage involved the annotation of biological mechanisms for the pre-selected candidate causal SNPs using improved-gene set enrichment analysis. ICSNPathway analysis identified three candidate SNPs, two genes, twenty-one pathways, and three hypothetical biological mechanisms: (1) rs17651549 to microtubule-associated protein tau (MAPT) to protein domain specific binding (nominal p < 0.001, false discovery rate (FDR) < 0.001), neurogenesis (nominal p < 0.001, FDR < 0.001), regulation of neurogenesis (nominal p < 0.001, FDR = 0.001), positive regulation of axonogenesis (nominal p < 0.001, FDR = 0.001), regulation of protein polymerization (nominal p < 0.001, FDR = 0.004), negative regulation of organelle organization (nominal p < 0.001, FDR = 0.004), hsa01510 (nominal p < 0.001, FDR = 0.005), neuron differentiation (nominal p < 0.001, FDR = 0.009), and axonogenesis (nominal p < 0.001, FDR = 0.009); (2) rs10445337 to MAPT to protein domain specific binding (nominal p < 0.001, FDR < 0.001), neurogenesis (nominal p < 0.001, FDR < 0.001), regulation of neurogenesis (nominal p < 0.001, FDR = 0.001), and positive regulation of axonogenesis (nominal p < 0.001, FDR = 0.001); (3) rs9938550 to HSD3B7 to hsa00363 (nominal p < 0.001, FDR = 0.004), bile acid metabolic process (nominal p = 0.005, FDR = 0.019), and steroid metabolic process (nominal p = 0.010, FDR = 0.039). By applying the ICSNPathway analysis to PD GWAS meta-analysis data, three candidate SNPs, two genes (MAPT and HSD3B7), and 21 pathways involving protein domain specific binding and neurogenesis were identified, which may contribute to PD susceptibility.
引用
收藏
页码:2599 / 2607
页数:9
相关论文
共 50 条
  • [41] Genome-Wide Association Studies and Liver Disease
    Speliotes, Elizabeth K.
    SEMINARS IN LIVER DISEASE, 2015, 35 (04) : 355 - 360
  • [42] Genome-wide association studies in Alzheimer disease
    Waring, Stephen C.
    Rosenberg, Roger N.
    ARCHIVES OF NEUROLOGY, 2008, 65 (03) : 329 - 334
  • [43] Genome-wide association studies in lung disease
    Soler Artigas, Maria
    Wain, Louise V.
    Tobin, Martin D.
    THORAX, 2012, 67 (03) : 271 - 273
  • [44] GENOME-WIDE ASSOCIATION STUDIES OF CARDIOVASCULAR DISEASE
    Walsh, Roddy
    Jurgens, Sean J.
    Erdmann, Jeanette
    Bezzina, Connie R.
    PHYSIOLOGICAL REVIEWS, 2023, 103 (03) : 2039 - 2055
  • [45] Genome-Wide Association Studies and Infectious Disease
    Bowcock, Anne M.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2010, 30 (03) : 305 - 309
  • [46] What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
    Fernandez-Santiago, Ruben
    Sharma, Manu
    AGEING RESEARCH REVIEWS, 2022, 79
  • [47] Genome-wide microsatellite association studies for sporadic Parkinson's disease by using the pooled DNA method
    Toda, T
    Satake, W
    Mizuta, L
    Yamamoto, M
    Hattori, N
    Murata, M
    MOVEMENT DISORDERS, 2004, 19 : S357 - S357
  • [48] Genome-wide microsatellite association studies for Parkinson's disease by using the pooled DNA method.
    Hirota, Y
    Momose, Y
    Satake, W
    Murata, M
    Tamiya, G
    Ikuta, T
    Makino, S
    Mizuta, I
    Yamamoto, M
    Hattori, N
    Inoko, H
    Toda, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 469 - 469
  • [49] Ethnicity-specific genome-wide association study in Parkinson's disease
    Chung, S. J.
    Choi, N.
    Kim, J.
    Kim, K.
    Kim, M. -J.
    Kim, Y. J.
    Ryu, H. -S.
    Park, K. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 252 - 252
  • [50] Neuroinflammation genomic markers in genome-wide association study of Parkinson's disease
    Chung, S. J.
    Choi, N.
    Kim, J.
    Kim, K.
    Kim, M. -J.
    Kim, Y. J.
    Ryu, H. -S.
    Park, K. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 68 - 68